FDA authorizes Pfizer’s COVID-19 vaccine booster for U.S. adults

Reuters

– The U.S. Food and Drug Administration on Friday authorized booster doses of Pfizer Inc and BioNTech SE’s COVID-19 vaccine for all adults, a move aimed at addressing waning protection among fully vaccinated Americans in the face of Delta variant-driven breakthrough cases of the illness.

Earlier in the day, Moderna said the FDA extended the emergency use authorization of a booster dose of its COVID-19 vaccine to all adults aged 18 and older.

A U.S. Centers for Disease Control and Prevention advisory panel is expected to meet later in the day to discuss whether to recommend the booster doses for the broader population.

Related News:   Russian anti-war poet gets seven-year jail term over poem on Ukraine war

(Reporting by Manas Mishra in Bengaluru, Editing by Caroline Humer and Bill Berkrot)

tagreuters.com2021binary_LYNXMPEHAI0P3-BASEIMAGE


You appear to be using an ad blocker

Shore News Network is a free website that does not use paywalls or charge for access to original, breaking news content. In order to provide this free service, we rely on advertisements. Please support our journalism by disabling your ad blocker for this website.